Nevro Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
November 01, 2023 at 04:01 pm EDT
Share
Nevro Corp. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was USD 103.86 million compared to USD 100.47 million a year ago. Net loss was USD 23.48 million compared to net income of USD 81.51 million a year ago. Basic loss per share from continuing operations was USD 0.65 compared to basic earnings per share from continuing operations of USD 2.3 a year ago. Diluted loss per share from continuing operations was USD 0.65 compared to diluted earnings per share from continuing operations of USD 2.22 a year ago.
For the nine months, sales was USD 309 million compared to USD 292.52 million a year ago. Net loss was USD 83.23 million compared to net income of USD 22.19 million a year ago. Basic loss per share from continuing operations was USD 2.32 compared to basic earnings per share from continuing operations of USD 0.63 a year ago. Diluted loss per share from continuing operations was USD 2.32 compared to diluted earnings per share from continuing operations of USD 0.63 a year ago.
Nevro Corp. is a global medical device company. The Company is focused on delivering solutions that continue to set the standard for enduring patient outcomes in chronic pain treatment. Its comprehensive HFX spinal cord stimulation 3 (SCS) platform includes the Senza SCS system and support services for the treatment of chronic pain of the trunk and limb and painful diabetic neuropathy. It has developed and commercialized its HFX spinal cord stimulation (SCS) platform, which includes the Senza SCS system, an evidence-based neuromodulation system for the treatment of chronic pain, with the Senza HFX iQ platform. Its HFX solution delivers a range of waveforms, including its paresthesia-free 10 kHz Therapy. Its 10 kHz Therapy is designed to deliver neuromodulation solutions for treating chronic pain. Its products include Senza II SCS System, Senza Omnia SCS System, Senza Omnia upgrade, Omnia Powered by HFX Connect, Senza HFX iQ System, and Surpass Surgical Lead.